Form D · Biotechnology

PNP THERAPEUTICS INC

Birmingham, AL · CIK 0001156062

Offering snapshot reported Aug 17, 2018 · SEC filing

Reported sold
$124K
Offering amount: $768K
Investors reported
9
Form D · investor count
Minimum accepted
$1.5K
Reported outside-investor minimum
First sale
Aug 8, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 17, 2018Initial$123,936No comparison9SEC filing
Jun 15, 2016Amendment$336,000$49,000vs May 5, 201614SEC filing
May 5, 2016Initial$287,000No comparison13SEC filing
Oct 1, 2014Initial$394,000No comparison10SEC filing
Sep 25, 2013Initial$212,000No comparison6SEC filing
Jun 27, 2012Initial$673,000No comparison5SEC filing
Oct 31, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-319553

Source: Form D, filed Aug 17, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Claude Bennett Director
William B. Deal Director
David A. Dodd Director
James F Fuqua Director, Executive
Lawrence W Greer Director
Frank R. Hunt Executive
John Lankford Director
William B Parker Director, Executive
Charles K Porter Director
Eric Sorscher Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
15 Richard Arrington Jr. Boulevard North
Birmingham, AL, 35203